表达外切酶的ILC3:在移植物抗宿主病中耗竭的免疫抑制性先天细胞
异基因造血干细胞移植常伴组织损伤并诱发GVHD。研究发现人ILC3新亚群共表达CD39和CD73(ecto+ ILC3),表达RORγt,存在于口胃肠道和骨髓,其外切酶表达受IL-1β调控,eATP刺激其产生IL-22和腺苷,并通过腺苷抑制自体T细胞增殖。移植受者肠道GVHD与ecto+ ILC3比例降低及腺苷/肌苷水平下降相关。
要点
- 人ecto+ ILC3共表达CD39和CD73,表达RORγt,分布于口胃肠道和骨髓。
- eATP刺激ecto+ ILC3产生IL-22和腺苷,腺苷介导其对自体T细胞增殖的抑制。
- 肠道GVHD与ecto+ ILC3比例降低及腺苷和肌苷水平下降相关。
核心结论
- ecto+ ILC3具有免疫抑制特性,但在GVHD患者中耗竭。
- ecto+ ILC3缺乏及中和DAMPs能力下降可能参与GVHD发生。
研究设计与样本
- 实验研究,涉及人ILC3亚群鉴定、体外功能实验及allo-HSCT受者样本分析。
主要发现
- 人ILC3新亚群共表达CD39和CD73(ecto+ ILC3),表达RORγt,存在于口胃肠道和骨髓。
- ILC3外切酶表达受促炎细胞因子IL-1β调控。
- eATP刺激ecto+ ILC3产生IL-22和腺苷。
- 活化ecto+ ILC3在共培养中通过产生腺苷抑制自体T细胞增殖。
- allo-HSCT受者肠道GVHD与ecto+ ILC3比例降低及腺苷和肌苷水平下降相关。
临床怎么用
- ecto+ ILC3及腺苷/肌苷水平可能作为GVHD相关免疫状态的观察指标。
- IL-1β调控ecto+ ILC3外切酶表达,提示炎症环境可能影响其免疫抑制功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is often associated with chemotherapy- and radiotherapy-induced host tissue damage, leading to graft-versus-host disease (GVHD). Innate lymphoid cells (ILC) have an essential role in tissue homeostasis and tissue repair via their production of interleukin (IL)-22, which acts on intestinal stem cells. The tissue healing capacities of ILC via IL-22 in the context of allo-HSCT and GVHD has previously been demonstrated in a mouse model for acute GVHD. We investigated potential other ways of ILC-mediated tissue protection against GVHD. Tissue injury leads to the release of danger-associated molecular patterns (DAMPs). DAMPs interact with purinergic receptors and ectoenzymes on immune cells and induce pleiotropic effects, including activation of proinflammatory antigen-presenting cells and immunosuppressive effects via the generation of adenosine. Here, we report a novel subset of human ILC3 that coexpress the ectoenzymes CD39 and CD73 (ecto+ ILC3). Ecto+ ILC3 express RORγt and were present in the oral-gastrointestinal tract and bone marrow. ILC3 ectoenzyme expression is modulated by the proinflammatory cytokine IL-1β. Extracellular adenosine triphosphate (eATP) stimulated ecto+ ILC3 to produce IL-22 and adenosine. Activated ecto+ ILC3 suppressed autologous T-cell proliferation in coculture experiments via the production of adenosine. In allo-HSCT recipients, intestinal GVHD was associated with reduced proportions of ecto+ ILC3 and decreased levels of adenosine and its metabolite inosine. Taken together, ecto+ ILC3 have immunosuppressive properties, but in patients with GVHD, ecto+ ILC3 are depleted. A lack of ecto+ ILC3 and subsequent reduced capacity to neutralize DAMPs may contribute to the development of GVHD.
引用
- Hazenberg MD, Haverkate NJE, van Lier YF, et al. Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease. Blood Adv. 2019. PMID: 31751473. doi:10.1182/bloodadvances.2019000176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。